Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2020 Filed Feb 11, 2020 00:16 UTC |
Nixon Ronald TDirector · 10% owner
|
ConversionCommon Stock | 179,101 | $9.00 | $1,611,909.00 |
DisclosureSEC source: 0000897423-20-000029 · edgar.xml · nonDerivative · entry 2 Nixon Ronald T · CIK 0001322573 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,452,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. F2 · ownership.nature: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Nixon is a manager of Catalyst Rochal, LLC. By virtue of these relationships, Mr. Nixon, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Nixon and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. F3 · ownership.nature: The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 00:16 UTC |
Nixon Ronald TDirector · 10% owner
|
ConversionCommon Stock | 2,273,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000029 · edgar.xml · nonDerivative · entry 1 Nixon Ronald T · CIK 0001322573 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,273,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series F Convertible Preferred Stock was convertible into Common Stock at any time on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for-1 in accordance with the terms of the Series F Convertible Preferred Stock. F1 · ownership.nature: The Series F Convertible Preferred Stock was convertible into Common Stock at any time on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for-1 in accordance with the terms of the Series F Convertible Preferred Stock. F2 · ownership.nature: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Nixon is a manager of Catalyst Rochal, LLC. By virtue of these relationships, Mr. Nixon, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Nixon and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:02 UTC |
CGI Cellerate RX, LLC10% owner
Catalyst Rochal, LLC10% owner
Gurasich Bradley J.10% owner
|
Conversion5% Convertible Promissory Note · Derivative | Not disclosed | Not disclosed Strike: $9.00 | $1,611,911.00 |
DisclosureSEC source: 0000908662-20-000031 · edgar.xml · derivative · entry 4 CGI Cellerate RX, LLC · CIK 0001766396 · 10% owner Catalyst Rochal, LLC · CIK 0001766398 · 10% owner Gurasich Bradley J. · CIK 0001766399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 179,101 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. F3 · price: The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. F2 · ownership.direct: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:02 UTC |
CGI Cellerate RX, LLC10% owner
Catalyst Rochal, LLC10% owner
Gurasich Bradley J.10% owner
|
ConversionSeries F Convertible Preferred Stock · Derivative | 1,136,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000908662-20-000031 · edgar.xml · derivative · entry 3 CGI Cellerate RX, LLC · CIK 0001766396 · 10% owner Catalyst Rochal, LLC · CIK 0001766398 · 10% owner Gurasich Bradley J. · CIK 0001766399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,273,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. F1 · price: The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. F1 · derivative.exercise_date: The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. F1 · derivative.expiration_date: The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. F2 · ownership.direct: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:02 UTC |
CGI Cellerate RX, LLC10% owner
Catalyst Rochal, LLC10% owner
Gurasich Bradley J.10% owner
|
ConversionCommon Stock | 179,101 | $9.00 | $1,611,909.00 |
DisclosureSEC source: 0000908662-20-000031 · edgar.xml · nonDerivative · entry 2 CGI Cellerate RX, LLC · CIK 0001766396 · 10% owner Catalyst Rochal, LLC · CIK 0001766398 · 10% owner Gurasich Bradley J. · CIK 0001766399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,452,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. F2 · ownership.direct: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:02 UTC |
CGI Cellerate RX, LLC10% owner
Catalyst Rochal, LLC10% owner
Gurasich Bradley J.10% owner
|
ConversionCommon Stock | 2,273,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000908662-20-000031 · edgar.xml · nonDerivative · entry 1 CGI Cellerate RX, LLC · CIK 0001766396 · 10% owner Catalyst Rochal, LLC · CIK 0001766398 · 10% owner Gurasich Bradley J. · CIK 0001766399 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,273,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. F2 · ownership.direct: Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:05 UTC |
Nixon Ronald TDirector · 10% owner
|
GrantCommon Stock | 7,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000013 · edgar.xml · nonDerivative · entry 1 Nixon Ronald T · CIK 0001322573 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,229 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 22:12 UTC |
Salamone Ann BealDirector
|
GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000021 · edgar.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 22:04 UTC |
Thorpe Kenneth EDirector
|
GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000020 · edgar.xml · nonDerivative · entry 1 Thorpe Kenneth E · CIK 0001482846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:58 UTC |
McNeil Michael D.Chief Financial Officer
|
GrantCommon Stock | 8,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000019 · edgar.xml · nonDerivative · entry 2 McNeil Michael D. · CIK 0001737969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,637 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:58 UTC |
McNeil Michael D.Chief Financial Officer
|
GrantCommon Stock | 2,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000019 · edgar.xml · nonDerivative · entry 1 McNeil Michael D. · CIK 0001737969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,540 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:50 UTC |
Carmena J MichaelDirector · Principal Executive Officer
|
GrantCommon Stock | 12,049 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000018 · edgar.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:50 UTC |
Carmena J MichaelDirector · Principal Executive Officer
|
GrantCommon Stock | 5,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000018 · edgar.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC |
Bowman Shawn M.President - Wound Care Div.
|
GrantCommon Stock | 13,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,065 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC |
Bowman Shawn M.President - Wound Care Div.
|
GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC |
Bowman Shawn M.President - Wound Care Div.
|
GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,510 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:26 UTC |
STUCKERT JAMES WDirector · 10% owner
|
GrantCommon Stock | 7,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000015 · edgar.xml · nonDerivative · entry 1 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,059 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:33 UTC |
Fleming Zachary B.President - Surgical Div.
|
GrantCommon Stock | 13,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000016 · edgar.xml · nonDerivative · entry 2 Fleming Zachary B. · CIK 0001799602 · President - Surgical Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,105 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:33 UTC |
Fleming Zachary B.President - Surgical Div.
|
GrantCommon Stock | 4,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000016 · edgar.xml · nonDerivative · entry 1 Fleming Zachary B. · CIK 0001799602 · President - Surgical Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:16 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
GrantCommon Stock | 7,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000014 · edgar.xml · nonDerivative · entry 1 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,394 Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:57 UTC |
Nixon Ronald TDirector · 10% owner
|
PurchaseCommon Stock | 963,856 | $8.30 | $8,000,004.80 |
DisclosureSEC source: 0000897423-19-000065 · edgar.xml · nonDerivative · entry 1 Nixon Ronald T · CIK 0001322573 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 963,856 F1 · ownership.nature: Reflects shares of Common Stock owned of record by FA Sanara, LLC ("FA Sanara"). FA Sanara is managed by Family Alignment, LLC ("Family"), which is managed by Catalyst Group, Inc.("Catalyst"). Mr. Nixon is controlling shareholder and President of Catalyst. Brad Gurasich has an economic interest in FA Sanara and is a manager of FA Sanara and Family. Mr. Nixon, Mr. Gurasich, Catalyst, Family and FA Sanara may be deemed to share voting and dispositive control over the Common Stock. Mr. Nixon, Mr. Gurasich, Catalyst and Family disclaim beneficial ownership of any Common Stock held or beneficially owned by FA Sanara, except to the extent of each of their pecuniary interests therein. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 21:24 UTC |
STUCKERT JAMES WDirector · 10% owner
|
PurchaseCommon Stock | 180,723 | $8.30 | $1,500,000.90 |
DisclosureSEC source: 0000897423-19-000064 · edgar.xml · nonDerivative · entry 1 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814,830 Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 21:20 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
PurchaseCommon Stock | 60,241 | $8.30 | $500,000.30 |
DisclosureSEC source: 0000897423-19-000063 · edgar.xml · nonDerivative · entry 1 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,165 Read SEC document |
| February 27, 2018 Filed May 10, 2018 00:04 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
OtherSeries C Preferred Stock · Derivative | 16,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001176488-18-000001 · primary_doc.xml · derivative · entry 5 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 19,817,165 shares Expires not disclosed F3 · derivative.exercise_price: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F3 · kind: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F3 · price: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F3 · derivative.expiration_date: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the Solomon Oden Howell Revocable Trust. Read SEC document |
| February 27, 2018 Filed May 10, 2018 00:04 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
OtherCommon Stock | 19,817,165 | $0.07 | $1,387,201.55 |
DisclosureSEC source: 0001176488-18-000001 · primary_doc.xml · nonDerivative · entry 3 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 42,092,429 F3 · kind: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F3 · shares: On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the Solomon Oden Howell Revocable Trust. Read SEC document |
| February 19, 2018 Filed May 10, 2018 00:04 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
OtherSeries C Preferred Stock · Derivative | 9,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001176488-18-000001 · primary_doc.xml · derivative · entry 4 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 16,535 Underlying: Common Stock · 10,799,586 shares Expires not disclosed F2 · derivative.exercise_price: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F2 · kind: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F2 · price: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F2 · derivative.expiration_date: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the Solomon Oden Howell Revocable Trust. Read SEC document |
| February 19, 2018 Filed May 10, 2018 00:04 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
OtherCommon Stock | 10,799,586 | $0.07 | $755,971.02 |
DisclosureSEC source: 0001176488-18-000001 · primary_doc.xml · nonDerivative · entry 2 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 22,125,264 F2 · kind: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F2 · shares: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the Solomon Oden Howell Revocable Trust. Read SEC document |
| February 19, 2018 Filed May 10, 2018 00:04 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
OtherCommon Stock | 11,325,678 | $0.07 | $792,797.46 |
DisclosureSEC source: 0001176488-18-000001 · primary_doc.xml · nonDerivative · entry 1 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,475,678 F1 · kind: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock. F1 · shares: On February 19, 2018, the Solomon Oden Howell Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the Solomon Oden Howell Revocable Trust. Read SEC document |
| February 19, 2018 Filed Jun 5, 2018 23:01 UTC |
STUCKERT JAMES WDirector · 10% owner
|
OtherSeries C Preferred Stock · Derivative | 3,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001176485-18-000001 · primary_doc.xml · derivative · entry 7 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Diane V. Stuckert Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 3,965,400 shares Expires not disclosed F3 · derivative.exercise_price: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F3 · kind: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F3 · price: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F3 · derivative.expiration_date: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F5 · ownership.nature: The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 19, 2018 Filed Jun 5, 2018 23:01 UTC |
STUCKERT JAMES WDirector · 10% owner
|
OtherSeries C Preferred Stock · Derivative | 36,384 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001176485-18-000001 · primary_doc.xml · derivative · entry 6 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By James W. Stuckert Revocable Trust Disclosed balance after: 0 Underlying: Common Stock · 43,037,070 shares Expires not disclosed F2 · derivative.exercise_price: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F2 · kind: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F2 · price: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F2 · derivative.expiration_date: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the trust. Read SEC document |
| February 19, 2018 Filed Jun 5, 2018 23:01 UTC |
STUCKERT JAMES WDirector · 10% owner
|
OtherCommon Stock | 3,965,400 | $0.07 | $277,578.00 |
DisclosureSEC source: 0001176485-18-000001 · primary_doc.xml · nonDerivative · entry 3 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Diane V. Stuckert Revocable Trust Disclosed balance after: 5,365,400 F3 · kind: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F3 · shares: On February 19, 2018, the Diane V. Stuckert Revocable Trust converted 3,572 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 3,965,400 shares of the Company's Common Stock. F5 · ownership.nature: The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 19, 2018 Filed Jun 5, 2018 23:01 UTC |
STUCKERT JAMES WDirector · 10% owner
|
OtherCommon Stock | 13,037,070 | $0.07 | $912,594.90 |
DisclosureSEC source: 0001176485-18-000001 · primary_doc.xml · nonDerivative · entry 2 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By James W. Stuckert Revocable Trust Disclosed balance after: 65,094,503 F2 · kind: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F2 · shares: On February 19, 2018, the James W. Stuckert Revocable Trust converted 36,384 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 43,037,070 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the trust. Read SEC document |
| February 19, 2018 Filed Jun 5, 2018 23:01 UTC |
STUCKERT JAMES WDirector · 10% owner
|
OtherCommon Stock | 11,325,678 | $0.07 | $792,797.46 |
DisclosureSEC source: 0001176485-18-000001 · primary_doc.xml · nonDerivative · entry 1 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By James W. Stuckert Revocable Trust Disclosed balance after: 22,057,433 F1 · kind: On February 19, 2018, the James W. Stuckert Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock. F1 · shares: On February 19, 2018, the James W. Stuckert Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock. F4 · ownership.nature: The reporting person is the trustee of the trust. Read SEC document |
| February 27, 2017 Filed Apr 4, 2017 00:34 UTC |
Rubinfeld Philip JDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001574181-17-000001 · primary_doc.xml · nonDerivative · entry 1 Rubinfeld Philip J · CIK 0001574181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
| February 27, 2017 Filed Apr 4, 2017 00:30 UTC |
HOWELL S ODEN JRDirector · 10% owner
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001176488-17-000003 · primary_doc.xml · nonDerivative · entry 1 HOWELL S ODEN JR · CIK 0001176488 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Solomon Oden Howell Revocable Trust Disclosed balance after: 150,000 F1 · ownership.nature: The reporting person is the trustee of the trust. Read SEC document |
| February 27, 2017 Filed Apr 6, 2017 00:14 UTC |
Siedhoff John ChristopherDirector
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001385213-17-000004 · primary_doc.xml · nonDerivative · entry 2 Siedhoff John Christopher · CIK 0001385213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,150,000 Read SEC document |
| February 27, 2017 Filed Apr 6, 2017 00:22 UTC |
STUCKERT JAMES WDirector · 10% owner
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001176485-17-000002 · primary_doc.xml · nonDerivative · entry 1 STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By James W. Stuckert Revocable Trust Disclosed balance after: 10,731,755 F1 · ownership.nature: The reporting person is the trustee of the trust. Read SEC document |
| October 24, 2016 Filed Mar 31, 2017 18:52 UTC |
HUTCHINSON DEBORAH JENKINSPresident
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001492839-17-000001 · primary_doc.xml · nonDerivative · entry 1 HUTCHINSON DEBORAH JENKINS · CIK 0001492839 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750,000 Read SEC document |
| February 20, 2015 Filed Apr 6, 2017 00:14 UTC |
Siedhoff John ChristopherDirector
|
ConversionSeries D Preferred Stock · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001385213-17-000004 · primary_doc.xml · derivative · entry 3 Siedhoff John Christopher · CIK 0001385213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015. F1 · derivative.exercise_date: The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015. F1 · derivative.expiration_date: The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015. Read SEC document |
| February 20, 2015 Filed Apr 6, 2017 00:14 UTC |
Siedhoff John ChristopherDirector
|
ConversionCommon Stock | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001385213-17-000004 · primary_doc.xml · nonDerivative · entry 1 Siedhoff John Christopher · CIK 0001385213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.